B
Baruch Yerushalmi
Researcher at Ben-Gurion University of the Negev
Publications - 89
Citations - 2486
Baruch Yerushalmi is an academic researcher from Ben-Gurion University of the Negev. The author has contributed to research in topics: Inflammatory bowel disease & Medicine. The author has an hindex of 25, co-authored 76 publications receiving 2111 citations. Previous affiliations of Baruch Yerushalmi include University of Colorado Denver & Soroka Medical Center.
Papers
More filters
Journal ArticleDOI
Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition
TL;DR: In conclusion, ROS generation, MPT induction, and cytochrome c release are critical steps in the induction of apoptosis by bile acids.
Journal ArticleDOI
Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children with Crohn???s Disease Compared with Reactive Monitoring
Amit Assa,Amit Assa,M Matar,Dan Turner,Efrat Broide,Batia Weiss,Batia Weiss,Oren Ledder,Anat Guz-Mark,Anat Guz-Mark,Firas Rinawi,Firas Rinawi,Shlomi Cohen,Shlomi Cohen,Chani Topf-Olivestone,Ron Shaoul,Baruch Yerushalmi,Raanan Shamir,Raanan Shamir +18 more
TL;DR: It is found that proactive monitoring of adalimumab trough concentrations and adjustment of doses and intervals resulted in significantly higher rates corticosteroid-free clinical remission than reactive monitoring (measuring trough concentration after loss of response).
Journal ArticleDOI
Role of oxidant stress in the permeability transition induced in rat hepatic mitochondria by hydrophobic bile acids.
Ronald J. Sokol,M. S. Straka,Rolf Dahl,Michael W. Devereaux,Baruch Yerushalmi,Eric Gumpricht,Nancy Elkins,Gregory T. Everson +7 more
TL;DR: It is proposed that reducing mitochondrial generation of reactive oxygen species or preventing increases in mitochondrial Ca2+ may protect the hepatocyte against bile acid-induced necrosis.
Journal ArticleDOI
Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency
Dror S. Shouval,Amlan Biswas,Amlan Biswas,Yu Hui Kang,Yu Hui Kang,Alexandra Griffith,Liza Konnikova,Liza Konnikova,Ivan D. Mascanfroni,Ivan D. Mascanfroni,Naresh Singh Redhu,Naresh Singh Redhu,Sandra M. Frei,Sandra M. Frei,Michael Field,Andria L. Doty,Jeff Goldsmith,Jeff Goldsmith,Atul K. Bhan,Anthony Loizides,Batia Weiss,Batia Weiss,Baruch Yerushalmi,Tadahiro Yanagi,Xiuli Lui,Francisco J. Quintana,Francisco J. Quintana,Aleixo M. Muise,Christoph Klein,Bruce H. Horwitz,Bruce H. Horwitz,Sarah C. Glover,Athos Bousvaros,Athos Bousvaros,Scott B. Snapper,Scott B. Snapper,Scott B. Snapper +36 more
TL;DR: The findings indicate that loss of IL10 signaling leads to intestinal inflammation, at least in part, through increased production of IL1 by innate immune cells, leading to activation of CD4+ T cells.
Journal ArticleDOI
Clinical and mutational spectrum of Mowat-Wilson syndrome
Christiane Zweier,Christian Thiel,Andreas Dufke,Yanick J. Crow,Peter Meinecke,Mohnish Suri,Sirpa Ala-Mello,Frits A. Beemer,Sergio Bernasconi,Paolo Emilio Bianchi,Andrea Bier,Koen Devriendt,Boyan Dimitrov,Helen V. Firth,Renata C. Gallagher,Livia Garavelli,Gabriele Gillessen-Kaesbach,Louanne Hudgins,Helena Kääriäinen,Susan Karstens,Ian D. Krantz,Anca Mannhardt,Livija Medne,Jürgen Mücke,Maria Kibaek,Lotte Nylandsted Krogh,Maarit Peippo,Olaf Rittinger,Solveig Schulz,Susan Schelley,I. Karen Temple,Nick Dennis,Marjo S. van der Knaap,Patricia G. Wheeler,Baruch Yerushalmi,Martin Zenker,Heide Seidel,Augusta M. A. Lachmeijer,Trine Prescott,Cornelia Kraus,R. Brian Lowry,Anita Rauch +41 more
TL;DR: Genotype-phenotype analysis confirmed that ZFHX1B deletions and stop mutations result in a recognizable facial dysmorphism with associated severe mental retardation and variable malformations such as Hirschsprung disease and congenital heart defects and indicates that structural eye anomalies such as microphthalmia should be considered as part of the MWS spectrum.